Description
Bizisa Injection is a chemotherapy medicine used to treat certain types of cancer, including chronic lymphocytic leukemia (CLL) and non-Hodgkin’s lymphoma (NHL). It contains Bendamustine, which works by damaging the DNA of cancer cells, preventing their growth and division.
How it Works:
-
Bendamustine is an alkylating agent that interferes with DNA replication, leading to cell death in rapidly dividing cancer cells.
Dosage:
-
Administer as prescribed by your oncologist, usually via intravenous infusion in a hospital or clinical setting.
-
Dosage and frequency depend on the type and stage of cancer, as well as patient condition.
Side Effects:
-
Nausea and vomiting
-
Low blood cell counts (anemia, neutropenia, thrombocytopenia)
-
Fatigue or weakness
-
Fever or infection risk
-
Rare allergic reactions
Precautions:
-
Use only under strict medical supervision
-
Monitor blood counts and liver/kidney function during treatment
-
Not recommended for patients with severe infections or hypersensitivity to Bendamustine
-
Pregnant or breastfeeding women should avoid use
Storage:
Store according to manufacturer instructions, usually in a cool, dry place below 25°C. Keep out of reach of children.
Leave a Reply